Who makes CKD-330 1 Tab. and D085 1 Tab.?

CKD-330 1 Tab. and D085 1 Tab. is developed by Chong Kun Dang Pharmaceutical.

What development phase is CKD-330 1 Tab. and D085 1 Tab. in?

CKD-330 1 Tab. and D085 1 Tab. is in Phase 1.

Last reviewed 2026-04-19 · How we verify

CKD-330 1 Tab. and D085 1 Tab.

Chong Kun Dang Pharmaceutical · Phase 1 active Small molecule

At a glance

Generic name	CKD-330 1 Tab. and D085 1 Tab.
Sponsor	Chong Kun Dang Pharmaceutical
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CKD-330 1 Tab. and D085 1 Tab. CI brief — competitive landscape report
CKD-330 1 Tab. and D085 1 Tab. updates RSS · CI watch RSS
Chong Kun Dang Pharmaceutical portfolio CI